Soaak, a company using sound frequency therapy for conditions like anxiety and depression, aims to close a $28 million Series A in the coming months, co-founder Henry Penix tells Axios exclusively.
Why it matters: While studies suggest sound therapy is clinically beneficial for reducing symptoms of issues like anxiety and fibromyalgia, the research is still limited.